Absci Prices $50 Mln Public Offering To Advance AI-Driven Drug Programs
25/7 23:16
(RTTNews) - Absci Corporation (ABSI), a clinical-stage biopharma company leveraging generative AI for drug discovery, has priced an underwritten public offering of 16.67 million shares of its common stock at $3.00 per share....